Published in Neoplasia on December 01, 1999
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics. Breast Care (Basel) (2008) 0.75
Aberrant phosphorylation of SMAD4 Thr277-mediated USP9x-SMAD4 interaction by free fatty acids promotes breast cancer metastasis. Cancer Res (2017) 0.75
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet (1992) 4.10
Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat (1995) 3.88
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell (1987) 3.45
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A (1995) 2.94
Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. Proc Natl Acad Sci U S A (1998) 2.92
Halting angiogenesis suppresses carcinoma cell invasion. Nat Med (1997) 2.61
Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res (1991) 2.45
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res (1991) 2.08
Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res (1997) 1.83
Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation (1997) 1.71
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol (1999) 1.59
Inhibition of angiogenesis by antiestrogens. Cancer Res (1993) 1.28
The effect of androgen deprivation and radiation therapy on an androgen-sensitive murine tumor: an in vitro and in vivo study. Cancer J Sci Am (1997) 1.26
Geometric resistance to blood flow in solid tumors perfused ex vivo: effects of tumor size and perfusion pressure. Cancer Res (1989) 1.24
Treatment of cancer with radiation and drugs. J Clin Oncol (1996) 1.19
Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res (1994) 1.18
Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst (1993) 1.13
Microcirculation: its significance in clinical and molecular medicine. J Intern Med (1997) 1.12
Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Endocrinology (1996) 1.11
Disruption of estrogen receptor gene prevents 17 beta estradiol-induced angiogenesis in transgenic mice. Endocrinology (1996) 1.09
Physicochemical and genetic evidence for specific antiestrogen binding sites. Proc Natl Acad Sci U S A (1983) 1.06
Tissue-isolated human tumor xenografts in athymic nude mice. Microvasc Res (1994) 1.03
Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat (1997) 0.98
bFGF and tumor angiogenesis--back in the limelight? Nat Med (1997) 0.98
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer (1997) 0.97
Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. J Cancer Res Clin Oncol (1996) 0.91
Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies. Br J Cancer (1999) 0.90
Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res (1996) 0.90
Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. Clin Cancer Res (1998) 0.89
Molecular biology of breast carcinoma. World J Surg (1994) 0.87
A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. J Endocrinol (1981) 0.85
Resistance to flow through tissue-isolated transplanted rat tumours located in two different sites. Br J Cancer (1993) 0.85
Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy. J Clin Pathol (1997) 0.83
A method to quantitatively measure transcapillary transport of iodinated compounds in canine brain tumors with computed tomography. J Cereb Blood Flow Metab (1991) 0.83
Spatial heterogeneity in tumor perfusion measured with functional computed tomography at 0.05 microliter resolution. Cancer Res (1994) 0.83
Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer. Clin Cancer Res (1996) 0.83
An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action. Invest New Drugs (1997) 0.82
Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. Clin Cancer Res (1997) 0.82
The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis. Blood Coagul Fibrinolysis (1993) 0.80
Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity. Cancer Res (1992) 0.80
Estrogen receptor mutagenesis and hormone resistance. Cancer (1994) 0.79
Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys (1993) 0.79
Tamoxifen induces hypoxia in MCF-7 xenografts. Cancer Res (1997) 0.78
Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes. Int J Radiat Oncol Biol Phys (1995) 0.76
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (1998) 11.61
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med (1997) 6.86
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res (1995) 6.21
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Transport of molecules in the tumor interstitium: a review. Cancer Res (1987) 5.74
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med (2001) 5.54
Tumor induction of VEGF promoter activity in stromal cells. Cell (1998) 5.20
Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04
Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res (2000) 4.89
MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med (1995) 4.72
The respiration of Mycobacterium phlei. Biochem J (1947) 4.09
Fractals and cancer. Cancer Res (2000) 4.05
Respiration and nutritional requirements of certain members of the genus Mycobacterium. Biochem J (1943) 3.94
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A (2001) 3.88
Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res (1994) 3.84
Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res (1992) 3.77
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res (1994) 3.54
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res (2000) 3.39
Diffusion of macromolecules in agarose gels: comparison of linear and globular configurations. Biophys J (1999) 3.26
Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol (1998) 3.18
During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med (1996) 3.18
Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res (1990) 3.18
Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A (2000) 3.16
Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res (1992) 3.09
Microvascular permeability of normal and neoplastic tissues. Microvasc Res (1986) 3.04
Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. Proc Natl Acad Sci U S A (2001) 2.96
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol (2001) 2.89
Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc Res (1989) 2.82
Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol (1997) 2.66
Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res (2000) 2.64
Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci U S A (1989) 2.61
Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol (2008) 2.61
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res (2001) 2.48
Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res (1991) 2.45
Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56. J Virol (1998) 2.41
Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. Biophys J (1993) 2.36
Needle stick injuries among health care workers in a tertiary care hospital of India. Indian J Med Res (2010) 2.32
Hindered diffusion in agarose gels: test of effective medium model. Biophys J (1996) 2.24
Acute stroke: improved nonenhanced CT detection--benefits of soft-copy interpretation by using variable window width and center level settings. Radiology (1999) 2.18
Global status of tospovirus epidemics in diverse cropping systems: successes achieved and challenges ahead. Virus Res (2009) 2.14
Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res (2001) 2.11
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res (1999) 2.10
Extravascular diffusion in normal and neoplastic tissues. Cancer Res (1984) 2.04
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res (1999) 2.00
Direct in vivo measurement of targeted binding in a human tumor xenograft. Proc Natl Acad Sci U S A (1997) 1.95
Diffusion and partitioning of proteins in charged agarose gels. Biophys J (1995) 1.92
Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc Natl Acad Sci U S A (1998) 1.88
Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol (1996) 1.86
Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci (1983) 1.85
Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. Proc Natl Acad Sci U S A (1999) 1.82
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med (1994) 1.80
Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res (1991) 1.73
Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation (1997) 1.71
Oncotic pressure in solid tumors is elevated. Cancer Res (2000) 1.69
Interstitial hypertension in human breast and colorectal tumors. Cancer Res (1992) 1.67
Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res (1993) 1.66
Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvasc Res (1995) 1.65
Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol (1997) 1.64
Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. Am J Physiol (1996) 1.63
Tumor angiogenesis and interstitial hypertension. Cancer Res (1996) 1.63
Secondary tuberculosis of the skin. Clinical features and problems in laboratory diagnosis. Int J Dermatol (1987) 1.62
Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer (2000) 1.60
Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation. Biophys J (1996) 1.60
Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res (2001) 1.59
Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol (1998) 1.58
Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics. Microvasc Res (1990) 1.54
Efficacy and safety of tenecteplase in ST elevation myocardial infarction patients from the Elaxim Indian Registry. Indian Heart J (2010) 1.50
Demonstration of intramedullary tuberculomas by magnetic resonance imaging: a report of two cases. Br J Radiol (1991) 1.50
Vascular morphogenesis and remodeling in a human tumor xenograft: blood vessel formation and growth after ovariectomy and tumor implantation. Circ Res (2001) 1.50
Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res (1992) 1.49
Tretinoin peels versus glycolic acid peels in the treatment of Melasma in dark-skinned patients. Dermatol Surg (2004) 1.48
Simplified measurement of deoxyglucose utilization rate. J Nucl Med (1996) 1.48
Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. Cancer Res (1995) 1.46
Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev (1998) 1.45
Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res (1994) 1.45
Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res (1994) 1.45
Chorea as a paraneoplastic complication of Hodgkin's disease. J Neurooncol (1998) 1.44
Analysis of cell flux in the parallel plate flow chamber: implications for cell capture studies. Biophys J (1994) 1.44
Maintenance and stability of introduced genotypes in groundwater aquifer material. Appl Environ Microbiol (1987) 1.44
Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. Microvasc Res (1991) 1.43
Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens (2012) 1.43
Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res (1996) 1.43
Formation of endothelial cell networks. Nature (2000) 1.43
Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res (1996) 1.43
Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J Virol (2000) 1.43
Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol (2000) 1.40
Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc Res (1996) 1.40